Robert E. Gagnon
Chief Financial Officer
Chief Financial Officer at Opus Genetics, Inc., filing insider transactions on 2026-04-23.
Total Purchases
—
0 transactions
Total Sales
$41K
1 transaction
Companies Traded
1
1 total filings
Active Since
2026-04-23
Last: 2026-04-23
Other Reporting Insiders at Opus Genetics, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-04-23 | IRD | Sale | 7,842 | $5.18 | $41K | 592.2K | SEC ↗ |
Head of Fin. Quality Assurance